Early Results of Extreme Hypofractionation Using Stereotactic Body Radiation Therapy for High-risk, Very High-risk and Node-positive Prostate Cancer
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 30 (7) , 442-447
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe Lancet Oncology, 2016
- Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialThe Lancet Oncology, 2016
- Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patientsActa Oncologica, 2012
- Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) GyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Carcinoma: Final Results of Phase III Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- A Phase II Trial of Arc-Based Hypofractionated Intensity-Modulated Radiotherapy in Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Phase II Trial of Hypofractionated Image-Guided Intensity-Modulated Radiotherapy for Localized Prostate AdenocarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate CancerJournal of Clinical Oncology, 2005
- Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003